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Abstract: A comparative study of the use of first derivative zero order crossing spectra for the resolution of Paracetamol 
and Tramadol hydrochloride in mixtures has been achieved showing the success of the first derivative method in resolving 
and quantifying both compounds. Using the first derivative, rather than the second derivative, results in improved signal 
to noise ratio. The absorption spectra of prepared mixtures were scanned in the range of 200-500 nm. The linear 
concentration ranges were 25-112 and 6-48 µg mL-1 for paracetamol and Tramadol hydrochloride, respectively. The 
method has been successfully used for prediction of concentrations of both compounds in mixtures with good selectivity, 
high sensitivity and extremely low relative error. Statistical comparison was performed using t-test at 95% confidence 
level. There was no significant statistical difference between the results obtained by the first derivative method and the 
accepted values for both compounds. Also, the percentage errors were very low which adds to the merits of our work in 
terms of both sensitivity and accuracy. 
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INTRODUCTION 
 Tramadol -HCl (±cis-2-[(dimethyl amino) methyl]-1- (m-
methoxyphenyl) cyclohexanol hydrochloride) and parace-
tamol (N-(4-hydroxyphenyl) acetamide) have been extensi-
vely used as antipyretic and analgesic drugs [1] (Scheme 1). 













Scheme 1. Structure of Paracetamol (a) and Tramadol (b). 
 Paracetamol (PR) or acetaminophen (the name of the 
drug in US, Scheme 1) is the most famous drug in treatment 
of pain and fever. It is used as antipyretic, analgesic and anti-
inflammatory drug, due to inhibiting prostaglandin synthesis 
cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) 
[1]. However, Paracetamol does not cause cancer like 
phenacetin [2]. Also, it has no effect on respiration. 
Although there are lots of drugs that work like paracetamol, 
it is still the most important, because it is  
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cheap, effective, has no side effects and most important, 
safe. Can be used alone to treat little to moderate pain, but if 
we combine it with anti-inflammatory steroid drugs or opioid 
it can treat intense pain [3]. Even then it is safe, but the 
overuse of it can lead to hepatic toxem. It can also lead to 
serious condition if it is taken it with alcohol. It is considered 
as the primary reason for toxemia in USA, UK and the New 
Zealand [4-7]. 
 Paracetamol was invented by Harmon Northrop Morse 
by reduction of para-nitro phenol with tin and glacial acetic 
acid [8]. However, it had not been used until 1893 in clinical 
treatment. The chemists produced paracetamol as white 
crystalline compound after it was found in urine of people 
that uptake phenacetin [9]. 
 Although paracetamol has been used for more than a 
century but until now the mechanism of action of 
paracetamol has not been discovered yet, because a number 
of characteristics are commons between paracetamol and 
aspirin in effect on prostaglandin compound that cause the 
inflammation. However, it doesn't affect on thrombocytes 
compound that cause coagulation like aspirin. Two 
mechanisms were suggested for how paracetamol works but 
these are not proved yet [10-13]. 
 Tramadol hydrochloride (TR) is a compound contains 
two enantiomers both of them achieve analgesic activity via 
different mechanisms. Tramadol efficiency has been 
observed to be improved by combining it with non-opioid 
analgesics [14]. 
 Determination of Paracetamol has been performed using 
various methods like reversed-phase high performance liquid 
chromatographic (RP-HPLC) with caffeine [1], in 
Pharmaceutical Mixture Using HPLC and GC–MS [15], by 
first-order derivative spectrophotometery in combination 
with ambroxol hydrochloride, levocetirizine dihydrochloride, 
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and phenylephrine hydrochloride [16].  By RP-HPLC in 
combination with Chlorzoxazone, and Nimesulide [17]. By 
RP-HPLC in combination with metoclopramide 
hydrochloride in tablet dosage form [18]. By colorimetric 
analysis [19]. Analysis, with codeine phosphate, using a RP-
HPLC system with manual injector has also been reported 
[20]. Solid–phase extraction, using deuterated internal 
standards, and gas chromatography-mass spectrometry has 
also been used [21].  
 Several methods have also been used for the determination 
of tramadol, high performance thin layer chromatography [22], 
simple spectrophotometric [23], tramadol and its metabolites in 
blood were identified in drugs-related deaths [24], and in 
combination with morphine as a percentage of opioid analgesic 
items [25]. Spectrophotometric determination of tramadol in 
pharmaceutical dosage forms was also achieved [26]. Liquid 
chromatography (LC) was used to determine tramadol in 
combination with Aceclofenac in a commercial tablet [27]. 
Ultrafiltration and LC-MS/MS in combination of O-
desmehtyltramadol and N-desmethyltramadol in plasma [28], 
by Meta-analysis [29], and by GC-MS in human urine [30]. 
 Several analytical procedures have been reported for the 
determination of the combined two compounds. A meta-
analysis for single dose oral in acute postoperative pain was 
conducted [31]. A RP-HPLC method in pharmaceutical 
dosage form [32], a spectrophotometric method in Tablet 
formulation in methanol and distilled water [33].By first 
derivative method [34], using HPLC-UV and GC-MS with a 
mobile phase consisting of phosphate buffer at pH 6.3 and 
acetonitrile [35], using just RP-HPLC by the mobile phase 
consisting of acetonitrilec - 0.26 % triethylamine [36], using 
LC-ESI-MS [37], by thin layer chromatographic 
densitometric method (LC) [38] and the same combination 
using RP-HPLC isocratic mobile phase consisting of 0.1 
%v/v trifluoroacetic acid: acetonitrile [39], by simple UV-
spectrophotometric method [40], by second derivative 
spectrophotometry [41], as well as a recent epidemiological 
analytical study on tramadol poisoning [42].  
DERIVATIVE SPECTRA ZERO-CROSSING TECHNIQUE 
 Assume a mixture of 2 components; x and y 
Am = Ax + Ay 
 At some λ1 we have: 
Am1 = εx1Cx + εy1Cy 
 Now, divide the absorbance of the mixture by the 
absorbance of standard x (εx1Cxo) 
(Am1/ εx1Cxo) = (εx1Cx/ εx1Cxo) + (εy1Cy/ εx1Cxo) 
 This results in cancellation of εx 
(Am1/ εx1Cxo) = (Cx/Cxo) + (εy1Cy/ εx1Cxo) 
 Now take the derivative of the resulting equation with 
respect to λ. 
 Evidently, d/dλ(Cx/Cxo) = 0 as it is independent on 
wavelength. The resulting equation should read: 
d/dλ(Am1/ εx1Cxo) = 0 + d/dλ(εy1Cy/ εx1Cxo) 
 
 Now the resulting spectrum is related to the 
concentration of component y, where component x was 
totally excluded. If we are to calculate the concentration of x, 
we start our manipulation by dividing on absorbance of 
standard y. 
EXPERIMENTAL 
Materials and Methodology 
 All chemicals were of analytical grade and were used 
without further purification. Paracetamol 500 mg per tablet 
(Beit Jala Pharmaceutical CO.), ethanol, tramadol 
hydrochlorides 50 mg per tablet (Pharmacare PLC.), solvent 
is always absolute ethanol (Chempal) and distilled water in a 
(1:9) ratio, were used respectively. A UV-Vis 
spectrophotometer (GENYESYS 10 UV-Vis made in US), 
filter paper (made in China by HANGOW WHATMAN). A 
1.0 cm quartz cuvettes were used throughout this work. 
Preparation of Stock Solutions 
 25 mg of paracetamol and 50 mg tramadol hydrochloride 
were weighed and dissolved individually in a 100 ml 
measuring flask. Then the solutions were filtered using a 
conventional filter paper. From this, appropriate dilutions of 
the solutions were made to prepare 125 µg ml-1 and 60 µg 
ml-1 of paracetamol and tramadol hydrochloride stock 
solutions, respectively. Finally, 8 mixing solutions of both 
drugs were prepared using direct dilution. Table 1 presents a 
summary of the prepared mixtures. 
Table 1. Symbols and composition of mixtures used in this 
work. 
 
Mixture Symbol Paracetamol (ml) Tramadol (ml) 
Am2 2 8 
Am3 3 7 
Am4 4 6 
Am5 5 5 
Am6 6 4 
Am7 7 3 
Am8 8 2 
Am9 9 1 
RESULTS AND DISCUSSION 
Selection of Wavelength 
 The UV-Vis spectra of both drugs were collected in the 
range of 200-500 nm against a blank. Then the absorbance 
spectra of the eight mixture solutions were also collected in 
the same range, in agreement with previous studies (4-7). 
Scanning for Wavelength 
 All solutions have been scanned in the range from 200-
500 nm against a blank. Resulting spectra are shown in Figs. 
(1, 2). 
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Fig. (1). Spectrum for tramadol-HCl. 
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 In accordance with previously reported results, 
paracetamol has a characteristic absorption peak at about 249 
nm, while tramadol has an absorption peak at about 271 nm. 
These wavelengths will be used after application of the 
derivative zero crossing technique for the determination of 
both drugs in mixtures. 
 The absorbance of each mixture was divided by the 
absorbance of standard tramadol, in order to determine 
paracetamol in the mixture. Then the derivative of the result 
was taken, giving a derivative spectrum like the one shown 
in Fig. (3). 
 The same procedure was applied for the determination of 
tramadol, where the absorbance of each mixure was divided 
by the absorbance of standard paracetamol, then the 
derivative was taken and evaluated for the determination of 
tramadol. Fig. (4) illustrates the result. 
 
Fig. (3). Derivative zero-crossing spectrum for determination of paracetamol. 
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 Taking the distance of the peaks from bottom to top 
around 249 and 271 nm gives values necessary to quantify 
both paracetamol and tramadol, respectively, in mixtures. 
Plotting these values for paracetamol resulted in a linear 
calibration plot, where r2 = 0.9987. The resulting calibration 
plot for tramadol was also linear with excellent correlation 
coefficient (r2 = 0.9986). 
 The obtained results were further evaluated for 
determination of unknown mixtures of paracetamol and 
tramadol, excellent results were always obtained regardless 
of the ratio of paracetamol to tramadol in the mixture, 
showing a clear advantage over the simpler first derivative 
method as reported by Shukla et al. [38]. The relative error 
was always less than 2.0%. The obtained results were 
compared with the true results for several samples, the 
standard deviation of the difference and the t-test suggest 
that the reported method can be used effectively where 
actually no significant statistical difference can be observed. 
Results of these findings are summarized in Table 2. 
Table 2. Tests of Significance for paracetamol. 
 
True Value Exp. Value Recovery (%) RE Sd T95% 
25.0 25.11 100.4 0.44 
0.97 0.06 
37.5 37.78 100.7 0.747 
50.0 50.11 100.2 0.22 
62.5 61.45 98.3 1.68 
75.0 75.05 100.1 0.07 
87.5 89.11 101.8 1.0 
100.0 98.45 98.4 2.8 
112.5 113.11 100.5 1.0 
CONCLUSION 
 A simple and highly reliable derivative zero-crossing 
method is proved successful for the determination of 
paracetamol and tramadol in pharmaceutical tablets. The 
method uses very little, cheap, and environmentally friendly 
reagents. The method does not suffer from disadvantages of 
the direct first derivative method. Correlation coefficient and 
relative error were very good. Statistical comparison was 
performed using t-test at 95% confidence level where there 
was no significant difference between the results of the 
proposed method and the true values. 
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